Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-21-089392

Options or other derivatives

  • Director acquired 850,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DELUCCIA ROBERT J Director 2021-06-29 Grant or award · Stock Option +350,000 350,000 D
DELUCCIA ROBERT J Director 2021-07-01 Grant or award · Stock Option +500,000 500,000 D
Loading xslF345X03/tm2121425-1_4seq1.xml…